AllQuantitative Report
logoArgusOctober 15, 2020

ENTA: Lowering target price to $47.00

Symbols
ENTA
Sector(s)
Healthcare
Rating
Current Price
$49.41
Price Target
$NaN
Earnings Estimate
Summary

Enanta Pharmaceuticals Inc is an American biotechnology company focused on research and development of molecule drugs to cure viral infections and liver diseases.

Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Try it Free